Neuphoria Therapeutics NEUP
NASDAQ NEUP
$2.71 +0.02 (+0.74%)
At close: Nov 11, 2026 · 4:00 PM EST

Neuphoria Therapeutics (NEUP) Other Operating Expenses (2026)

Updated

Neuphoria Therapeutics (NEUP) reported Other Operating Expenses of $4.81 million for fiscal Q4 2026 (quarter ended Jun 30, 2026).

Analysis

Neuphoria Therapeutics (NEUP) Other Operating Expenses (2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Neuphoria Therapeutics posted Other Operating Expenses of $8.77 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Neuphoria Therapeutics 335.34 Mn 260.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.34 Mn
Mar 31, 2026 -1.04 Mn
API Access

Neuphoria Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=NEUP&period=max&api_key=YOUR_API_KEY